Alcami Overview
- Founded
-
1979

- Status
-
Private
- Employees
-
993

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
10
- Investments
-
4
Alcami General Information
Description
Operator of contract development and manufacturing organization (CDMO) intended for small and mid-sized pharmaceutical and biotechnology companies. The company offers formulation and analytical development, testing, microbial identification, stability storage and other laboratory-related services, enabling clients to avail of a less-fragmented, cost-effective and faster pathway for product commercialization.
Contact Information
Website
www.alcaminow.com
Formerly Known As
Cambridge Major Laboratories
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
BPO/Outsource Services
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
- 2320 Scientific Park Drive
- Wilmington, NC 28405
- United States
+1 (800) 000-0000
Alcami Timeline
Alcami Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Alcami Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of contract development and manufacturing organization (CDMO) intended for small and mid-sized pharmaceutical a
BPO/Outsource Services
Wilmington, NC
993
As of 2022
00.00
000000000000
Alcami Competitors (26)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Dalton Pharma Services | Corporate Backed or Acquired | Toronto, Canada | 000 | 000000&0 | ||
000000 | Private Equity-Backed | Clearwater, FL | 000 | 0000 | 000000 - 000 | |
000000 000000 | Private Equity-Backed | Durham, NC | 000 | 00.00 | 000000000 00 | 00.00 |
0000000000 | Private Equity-Backed | Cuxhaven, Germany | 00 | 000000000000 | ||
000 000000 0000000 | Private Equity-Backed | Philadelphia, PA | 0000 | 00000 | 000000000 | 00000 |
Alcami Patents
Alcami Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11642324-B1 | Topical tranexamic acid compositions and methods of use thereof | Active | 01-Mar-2022 | 0000000000 | 000 |
AU-2019350525-A1 | Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound | Pending | 26-Sep-2018 | 0000000000 | |
CA-3112993-A1 | Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound | Pending | 26-Sep-2018 | 0000000000 | |
EP-3856721-B1 | Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound | Active | 26-Sep-2018 | 0000000000 | |
EP-3856721-A1 | Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound | Active | 26-Sep-2018 | C07D231/38 |
Alcami Executive Team (24)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Patrick D. Walsh | Chief Executive Officer & Chairman of the Board | ||
Eric Evans | Chief Financial Officer | ||
Ken Domagalski | Chief Operating Officer | ||
Timothy Compton | Chief Business Officer | ||
Jamie Iudica | Chief Manufacturing Officer |
Alcami Board Members (12)
Name | Representing | Role | Since |
---|---|---|---|
0000 000000 | GHO Capital | Board Member | 000 0000 |
00000 00000 | Self | Board Member | 000 0000 |
00000000 000000000 | Alcami | Board Member | 000 0000 |
0000000 00000000 | GHO Capital | Board Member | 000 0000 |
0000000 00000 | Vistria Group | Board Member | 000 0000 |
Alcami Signals
Alcami Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Alcami Investments (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 00000000 | 15-Dec-2021 | 0000000000 | Laboratory Services (Healthcare) | 0000000 0 | |
00000000 0000 | 17-Jan-2020 | 0000000000 | Other Pharmaceuticals and Biotechnology | 000000 00 | |
000000000 000 | 02-Oct-2013 | 0000000000 | Other Pharmaceuticals and Biotechnology | ||
Cambridge Major Laboratories Europe | 16-Nov-2007 | Buyout/LBO | Pharmaceuticals | 0000000 0 |
Alcami Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
Masy Bioservices | Laboratory Services (Healthcare) | Pepperell, MA | 1984 |
00000000 00000000 | Other Pharmaceuticals and Biotechnology | Morrisville, NC |
Alcami Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000000000 00000 00 | 16-Nov-2007 | 0000000000 | Completed |
|